The Business of Alt Protein: Bringing Cultivated Meat to Market in the United States
Event description
In late 2022, the cultivated meat industry hit an important milestone – UPSIDE Foods became the first cultivated meat company to successfully complete the U.S. Food & Drug Administration (FDA)’s pre-market consultation. The FDA has also shared in a recent update that it is currently in pre-market consultation discussions with other cultivated meat companies.
As we come closer to full regulatory approval, join GFI experts to review the current status of the cultivated meat industry and to take a deep dive into the recent advancements that have taken place in the United States. In this webinar we will cover:
- Overview of the cultivated meat production process
- The US regulatory pathway
- Consumer messaging and nomenclature
- Audience Q&A with GFI scientific, regulatory, and market experts
Meet the speakers
Our speakers today include experts from GFI’s corporate engagement, science and technology, and policy teams. We will be joined by:
- Faraz Harsini, Senior Scientist, Bioprocessing
- Laura Braden, Lead Regulatory Counsel
- Madeline Cohen, Regulatory Attorney
- Emma Ignaszewski, Associate Director, Industry Intelligence & Initiatives
Upcoming events
View all events
The Science of Alt Protein: Plant protein colloidal state and techno-functionality
Take a deep dive into the importance of the colloidal state of proteins when using globular plant proteins as functional food ingredients.
The Science of Alt Protein: Bridging functionality gaps through hybrid food design
Join us to learn how plant proteins, microbial biomass, and precision-fermentation-derived ingredients can be integrated to create next-generation food products.
Business of Alt Protein: The Importance of Sensory Science for Alternative Proteins
Join us on June 30 for a Business of Alt Protein webinar on the importance of sensory science for alternative proteins.
